HEADER ANTITUMOR PROTEIN 16-NOV-25 9T9M TITLE TILVESTAMAB FAB BOUND TO THE ANTI-FAB NANOBODY COMPND MOL_ID: 1; COMPND 2 MOLECULE: LIGHT CHAIN OF BGB149 ANTIBODY; COMPND 3 CHAIN: L; COMPND 4 OTHER_DETAILS: LIGHT CHAIN CLEAVED FROM THE FULL-LENGTH BGB149 COMPND 5 ANTIBODY USING PAPAIN; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: ANTI NAB-FAB NANOBODY; COMPND 8 CHAIN: K; COMPND 9 OTHER_DETAILS: ANTI NAB-FAB NANOBODY; COMPND 10 MOL_ID: 3; COMPND 11 MOLECULE: HEAVY CHAIN OF BGB149 ANTIBODY; COMPND 12 CHAIN: H; COMPND 13 OTHER_DETAILS: HEAVY CHAIN CLEAVED FROM THE FULL-LENGTH BGB149 COMPND 14 ANTIBODY USING PAPAIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS SP.; SOURCE 3 ORGANISM_TAXID: 10095; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: MUS SP.; SOURCE 6 ORGANISM_TAXID: 10095; SOURCE 7 MOL_ID: 3; SOURCE 8 ORGANISM_SCIENTIFIC: MUS SP.; SOURCE 9 ORGANISM_TAXID: 10095 KEYWDS ANTI-AXL, MONOCLONAL ANTIBODY, CANCER, AXL IS A RECEPTOR TYROSINE KEYWDS 2 KINASE, ANTITUMOR PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR A.J.LOPEZ,E.CHRISTAKOU,P.KURSULA REVDAT 1 28-JAN-26 9T9M 0 JRNL AUTH E.CHRISTAKOU,A.J.LOPEZ,G.MURUGANANDAM,D.MICKLEM,J.B.LORENS, JRNL AUTH 2 P.KURSULA JRNL TITL STRUCTURAL ANALYSIS OF TILVESTAMAB IN COMPLEX WITH AXL. JRNL REF ACS OMEGA V. 11 1874 2026 JRNL REFN ESSN 2470-1343 JRNL PMID 41552498 JRNL DOI 10.1021/ACSOMEGA.5C10003 REMARK 2 REMARK 2 RESOLUTION. 3.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, CRYOSPARC, UCSF CHIMERAX, REMARK 3 CRYOSPARC, CRYOSPARC, CRYOSPARC, REMARK 3 CRYOSPARC, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 7PIJ REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : RIGID BODY FIT REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.090 REMARK 3 NUMBER OF PARTICLES : 131691 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9T9M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-DEC-25. REMARK 100 THE DEPOSITION ID IS D_1292151304. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : TILVESTAMAB FAB AND THE REMARK 245 ANTINABFAB NANOBODY; FAB REMARK 245 FRAGMENT OF TILVESTAMAB; ANTI REMARK 245 NAB-FAB NANOBODY, SYNTHETIC GENE REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.33 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : FAB FRAGMENT OF TILVESTAMAB REMARK 245 (BGB149, BERGENBIO, NORWAY), A HUMANIZED AXL MONOCLONAL ANTIBODY REMARK 245 (LIGHT AND HEAVY CHAIN), IT WAS COUPLED WITH AN ANTI-NAB-FAB REMARK 245 NANOBODY RECOMBINANT EXPRESSED IN E. COLI; FAB FRAGMENT OF REMARK 245 TILVESTAMAB (BGB149, BERGENBIO, NORWAY), A HUMANIZED AXL REMARK 245 MONOCLONAL ANTIBODY (LIGHT AND HEAVY CHAIN); SYNTHETIC GENE REMARK 245 RECOMBINANT EXPRESSED IN E. COLI REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 17189 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : DIFFRACTION REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5959.70 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 130000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, K, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP L 1 REMARK 465 GLY K 1 REMARK 465 SER K 2 REMARK 465 GLN K 3 REMARK 465 VAL K 4 REMARK 465 GLN K 5 REMARK 465 SER K 122 REMARK 465 SER K 123 REMARK 465 LYS H 134 REMARK 465 SER H 135 REMARK 465 THR H 136 REMARK 465 SER H 137 REMARK 465 GLY H 138 REMARK 465 GLY H 139 REMARK 465 PRO H 218 REMARK 465 LYS H 219 REMARK 465 SER H 220 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU L 52 -60.44 -101.29 REMARK 500 ARG L 55 -105.68 49.72 REMARK 500 SER L 70 -167.15 -167.07 REMARK 500 THR L 97 -64.07 -94.11 REMARK 500 PRO L 146 -169.46 -68.57 REMARK 500 VAL K 50 -57.56 -122.50 REMARK 500 VAL H 48 -62.90 -107.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-55722 RELATED DB: EMDB REMARK 900 TILVESTAMAB FAB BOUND TO THE ANTI-FAB NANOBODY DBREF 9T9M L 1 218 PDB 9T9M 9T9M 1 218 DBREF 9T9M K 1 123 PDB 9T9M 9T9M 1 123 DBREF 9T9M H 1 220 PDB 9T9M 9T9M 1 220 SEQRES 1 L 218 ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 L 218 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG SER SER SEQRES 3 L 218 GLN SER LEU VAL HIS SER ASN GLY ILE PRO TYR LEU HIS SEQRES 4 L 218 TRP TYR GLN GLN LYS PRO GLY LYS ALA PRO LYS LEU LEU SEQRES 5 L 218 ILE TYR ARG VAL SER ASN ARG PHE SER GLY VAL PRO SER SEQRES 6 L 218 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 L 218 THR ILE SER SER LEU GLN PRO GLU ASP PHE ALA THR TYR SEQRES 8 L 218 TYR CYS SER GLN GLY THR HIS VAL PRO PRO THR PHE GLY SEQRES 9 L 218 GLN GLY THR LYS VAL GLU ILE LYS ARG THR VAL ALA ALA SEQRES 10 L 218 PRO SER VAL PHE ILE PHE PRO PRO SER ASP GLU GLN LEU SEQRES 11 L 218 LYS SER GLY THR ALA SER VAL VAL CYS LEU LEU ASN ASN SEQRES 12 L 218 PHE TYR PRO ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP SEQRES 13 L 218 ASN ALA LEU GLN SER GLY ASN SER GLN GLU SER VAL THR SEQRES 14 L 218 GLU GLN ASP SER LYS ASP SER THR TYR SER LEU SER SER SEQRES 15 L 218 THR LEU THR LEU SER LYS ALA ASP TYR GLU LYS HIS LYS SEQRES 16 L 218 VAL TYR ALA CYS GLU VAL THR HIS GLN GLY LEU SER SER SEQRES 17 L 218 PRO VAL THR LYS SER PHE ASN ARG GLY GLU SEQRES 1 K 123 GLY SER GLN VAL GLN LEU GLN GLU SER GLY GLY GLY LEU SEQRES 2 K 123 VAL GLN PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SEQRES 3 K 123 SER GLY ARG THR ILE SER ARG TYR ALA MET SER TRP PHE SEQRES 4 K 123 ARG GLN ALA PRO GLY LYS GLU ARG GLU PHE VAL ALA VAL SEQRES 5 K 123 ALA ARG ARG SER GLY ASP GLY ALA PHE TYR ALA ASP SER SEQRES 6 K 123 VAL GLN GLY ARG PHE THR VAL SER ARG ASP ASP ALA LYS SEQRES 7 K 123 ASN THR VAL TYR LEU GLN MET ASN SER LEU LYS PRO GLU SEQRES 8 K 123 ASP THR ALA VAL TYR TYR CYS ALA ILE ASP SER ASP THR SEQRES 9 K 123 PHE TYR SER GLY SER TYR ASP TYR TRP GLY GLN GLY THR SEQRES 10 K 123 GLN VAL THR VAL SER SER SEQRES 1 H 220 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 H 220 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 H 220 TYR SER PHE THR ASP PHE TYR ILE ASN TRP VAL ARG GLN SEQRES 4 H 220 ALA PRO GLY LYS GLY LEU GLU TRP VAL ALA ARG ILE PHE SEQRES 5 H 220 PRO GLY GLY ASP ASN THR TYR TYR ASN GLU LYS PHE LYS SEQRES 6 H 220 GLY ARG PHE THR LEU SER ALA ASP THR SER LYS SER THR SEQRES 7 H 220 ALA TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 H 220 ALA VAL TYR TYR CYS ALA ARG ARG GLY LEU TYR TYR ALA SEQRES 9 H 220 MET ASP TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SEQRES 10 H 220 SER ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA SEQRES 11 H 220 PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU SEQRES 12 H 220 GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR SEQRES 13 H 220 VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS SEQRES 14 H 220 THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER SEQRES 15 H 220 LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY SEQRES 16 H 220 THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER SEQRES 17 H 220 ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SER HELIX 1 AA1 SER L 126 SER L 132 1 7 HELIX 2 AA2 LYS L 188 GLU L 192 1 5 HELIX 3 AA3 LYS K 89 THR K 93 5 5 HELIX 4 AA4 GLU H 62 LYS H 65 5 4 HELIX 5 AA5 ARG H 87 THR H 91 5 5 HELIX 6 AA6 SER H 161 ALA H 163 5 3 HELIX 7 AA7 PRO H 190 LEU H 194 5 5 SHEET 1 AA1 4 THR L 5 GLN L 6 0 SHEET 2 AA1 4 VAL L 19 ARG L 24 -1 O ARG L 24 N THR L 5 SHEET 3 AA1 4 ASP L 75 ILE L 80 -1 O PHE L 76 N CYS L 23 SHEET 4 AA1 4 PHE L 67 SER L 72 -1 N SER L 68 O THR L 79 SHEET 1 AA2 2 SER L 12 ALA L 13 0 SHEET 2 AA2 2 GLU L 110 ILE L 111 1 O GLU L 110 N ALA L 13 SHEET 1 AA3 5 ASN L 58 ARG L 59 0 SHEET 2 AA3 5 LYS L 50 TYR L 54 -1 N TYR L 54 O ASN L 58 SHEET 3 AA3 5 LEU L 38 GLN L 43 -1 N GLN L 42 O LYS L 50 SHEET 4 AA3 5 THR L 90 GLN L 95 -1 O TYR L 92 N TYR L 41 SHEET 5 AA3 5 THR L 107 LYS L 108 -1 O THR L 107 N TYR L 91 SHEET 1 AA4 4 SER L 119 PHE L 123 0 SHEET 2 AA4 4 THR L 134 PHE L 144 -1 O LEU L 140 N PHE L 121 SHEET 3 AA4 4 TYR L 178 SER L 187 -1 O LEU L 180 N LEU L 141 SHEET 4 AA4 4 SER L 164 VAL L 168 -1 N GLN L 165 O THR L 183 SHEET 1 AA5 3 LYS L 150 VAL L 155 0 SHEET 2 AA5 3 VAL L 196 THR L 202 -1 O GLU L 200 N GLN L 152 SHEET 3 AA5 3 VAL L 210 ASN L 215 -1 O VAL L 210 N VAL L 201 SHEET 1 AA6 4 GLN K 7 GLU K 8 0 SHEET 2 AA6 4 LEU K 20 ALA K 25 -1 O ALA K 25 N GLN K 7 SHEET 3 AA6 4 THR K 80 MET K 85 -1 O MET K 85 N LEU K 20 SHEET 4 AA6 4 PHE K 70 ASP K 75 -1 N THR K 71 O GLN K 84 SHEET 1 AA7 6 GLY K 12 LEU K 13 0 SHEET 2 AA7 6 THR K 117 THR K 120 1 O THR K 120 N GLY K 12 SHEET 3 AA7 6 ALA K 94 ASP K 101 -1 N ALA K 94 O VAL K 119 SHEET 4 AA7 6 MET K 36 GLN K 41 -1 N GLN K 41 O VAL K 95 SHEET 5 AA7 6 GLU K 48 ALA K 53 -1 O GLU K 48 N ARG K 40 SHEET 6 AA7 6 ALA K 60 TYR K 62 -1 O PHE K 61 N VAL K 52 SHEET 1 AA8 4 GLY K 12 LEU K 13 0 SHEET 2 AA8 4 THR K 117 THR K 120 1 O THR K 120 N GLY K 12 SHEET 3 AA8 4 ALA K 94 ASP K 101 -1 N ALA K 94 O VAL K 119 SHEET 4 AA8 4 TYR K 110 TRP K 113 -1 O TYR K 112 N ILE K 100 SHEET 1 AA9 4 GLN H 3 SER H 7 0 SHEET 2 AA9 4 SER H 17 SER H 25 -1 O SER H 21 N SER H 7 SHEET 3 AA9 4 THR H 78 ASN H 84 -1 O MET H 83 N LEU H 18 SHEET 4 AA9 4 PHE H 68 ASP H 73 -1 N THR H 69 O GLN H 82 SHEET 1 AB1 6 GLY H 10 VAL H 12 0 SHEET 2 AB1 6 THR H 112 VAL H 116 1 O THR H 115 N GLY H 10 SHEET 3 AB1 6 ALA H 92 ALA H 97 -1 N ALA H 92 O VAL H 114 SHEET 4 AB1 6 ILE H 34 GLN H 39 -1 N ASN H 35 O ALA H 97 SHEET 5 AB1 6 LEU H 45 ILE H 51 -1 O GLU H 46 N ARG H 38 SHEET 6 AB1 6 TYR H 59 TYR H 60 -1 O TYR H 59 N ARG H 50 SHEET 1 AB2 4 SER H 125 LEU H 129 0 SHEET 2 AB2 4 ALA H 141 TYR H 150 -1 O GLY H 144 N LEU H 129 SHEET 3 AB2 4 TYR H 181 VAL H 189 -1 O VAL H 187 N LEU H 143 SHEET 4 AB2 4 VAL H 168 THR H 170 -1 N HIS H 169 O VAL H 186 SHEET 1 AB3 4 SER H 125 LEU H 129 0 SHEET 2 AB3 4 ALA H 141 TYR H 150 -1 O GLY H 144 N LEU H 129 SHEET 3 AB3 4 TYR H 181 VAL H 189 -1 O VAL H 187 N LEU H 143 SHEET 4 AB3 4 VAL H 174 LEU H 175 -1 N VAL H 174 O SER H 182 SHEET 1 AB4 3 THR H 156 TRP H 159 0 SHEET 2 AB4 3 ILE H 200 HIS H 205 -1 O ASN H 202 N SER H 158 SHEET 3 AB4 3 THR H 210 LYS H 215 -1 O VAL H 212 N VAL H 203 SSBOND 1 CYS L 23 CYS L 93 1555 1555 2.03 SSBOND 2 CYS L 139 CYS L 199 1555 1555 2.03 SSBOND 3 CYS K 24 CYS K 98 1555 1555 2.03 SSBOND 4 CYS H 22 CYS H 96 1555 1555 2.03 SSBOND 5 CYS H 145 CYS H 201 1555 1555 2.03 CISPEP 1 VAL L 99 PRO L 100 0 -2.31 CISPEP 2 TYR L 145 PRO L 146 0 1.06 CISPEP 3 PHE H 151 PRO H 152 0 -4.74 CISPEP 4 GLU H 153 PRO H 154 0 -4.31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 156 710 CONECT 710 156 CONECT 1047 1526 CONECT 1526 1047 CONECT 1801 2386 CONECT 2386 1801 CONECT 2719 3314 CONECT 3314 2719 CONECT 3625 4039 CONECT 4039 3625 MASTER 158 0 0 7 53 0 0 6 4165 3 10 44 END